Literature DB >> 19822059

Mortality in rheumatoid arthritis and ankylosing spondylitis.

J Zochling1, J Braun.   

Abstract

The rheumatic diseases not only bring pain, disability and poorer quality of life, but also a premature mortality which is often overlooked. Alongside mortality due to the direct complications of disease comes an increase in deaths related to specific therapies and indirect causes such as cancer and cardiovascular mortality. By comparing mortality and its causes in two of the most common inflammatory arthritides, rheumatoid arthritis and ankylosing spondylitis, common threads emerge which give us insight into the impact of chronic inflammatory disease and new directions for patient management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822059

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  16 in total

Review 1.  [Development of morbidity and mortality in patients with spondyloarthritis].

Authors:  U Kiltz; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

2.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms].

Authors:  U Kiltz; M Rudwaleit; J Sieper; D Krause; J-F Chenot; A Stallmach; S Jaresch; U Oberschelp; E Schneider; B Swoboda; H Böhm; A Heiligenhaus; U Pleyer; W-H Böhncke; M Stemmer; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

3.  Functional genomics and rheumatoid arthritis: where have we been and where should we go?

Authors:  James N Jarvis; Mark Barton Frank
Journal:  Genome Med       Date:  2010-07-28       Impact factor: 11.117

4.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

5.  The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis.

Authors:  Ridvan Mercan; Berivan Bitik; Abdurrahman Tufan; Utku Burak Bozbulut; Nuh Atas; Mehmet Akif Ozturk; Seminur Haznedaroglu; Berna Goker
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

Review 6.  Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.

Authors:  Michael T Nurmohamed; Irene van der Horst-Bruinsma; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

7.  The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist.

Authors:  Ruben Burgos-Vargas
Journal:  Pediatr Rheumatol Online J       Date:  2012-05-31       Impact factor: 3.054

8.  The Relationship Between Serum Pentraxine 3 Levels and Hematological Markers in Patients With Rheumatoid Arthritis.

Authors:  Mustafa Serdar Sağ; Sinem Sağ; İbrahim Tekeoğlu; Ayhan Kamanli; Kemal Nas; Halil Harman
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

9.  Correlation between C-Reactive Protein to Albumin Ratio and Disease Activity in Patients with Axial Spondyloarthritis.

Authors:  Zheng Zhong; Yukai Huang; Yuqi Liu; Junming Chen; Meng Liu; Qidang Huang; Shaoling Zheng; Xin Guo; Weiming Deng; Tianwang Li
Journal:  Dis Markers       Date:  2021-06-12       Impact factor: 3.434

10.  Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care.

Authors:  Markus M J Nielen; Alper M van Sijl; Mike J L Peters; Robert A Verheij; François G Schellevis; Michael T Nurmohamed
Journal:  BMC Musculoskelet Disord       Date:  2012-08-21       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.